Cataract Diabetic: Clinical Trials

5 trials for Cataract Diabetic, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 unknown, 1 completed, 1 recruiting, 1 withdrawn. 2 Not applicable, 2 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable2Completed 1, Unknown 1
Phase 42Unknown 1, Withdrawn 1

Follow Cataract Diabetic: new trials by email Literature Review of Cataract Diabetic trials Research Report on Cataract Diabetic

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of the Impact of Cataract Surgery on the Corneal Epithelium and Ocular Surface of Diabetic Patients
Cataract Diabetic
RecruitingUniversity Hospital, Strasbourg, France1502024-04-222024-10-15
Phacoemulsification Combined With Intravitreal Injection of Ranibizumab Prevent Postoperative Capillary Non-perfusion Zone Progress in Non-proliferative Diabetic Retinopathy
Ranibizumab Injection [Lucentis], Phacoemulsification - Mild Non-proliferative Diabetic Retinopathy, Cataract Diabetic
Phase 4UnknownRuijin Hospital962022-07-012022-05-23
Dextenza vs Prednisolone Acetate After Cataract Surgery for Patients With Diabetes
Dextenza 0.4Mg Ophthalmic Insert, Prednisolone Acetate 1% Oph Susp - Cataract Diabetic, Macula Edema
Phase 4WithdrawnBaylor Research Institute2021-08-312026-03-02
Prophylactic Effect of Conbercept Intravitreal Injection at the Conclusion of Cataract Surgery for Diabetic Macular Edema
Conbercept intravitreal injection - Diabetic Macular Edema, Diabetic Retinopathy
Not applicableUnknownEye & ENT Hospital of Fudan University402021-01-012020-12-16
Safety of Trypan Blue on Endothelium of Diabetic Retinopathy Patients
Phacoemulsification with and without Trypan Blue capsule staining - Cataract Diabetic
Not applicableCompletedAssiut University652018-01-012018-11-28

Narrower conditions

Diabetic Retinopathy (2)  ·  Cataract (1)  ·  Diabetes Mellitus (1)

Broader conditions

Endocrine System Diseases (3)  ·  Eye Diseases (3)  ·  Cardiovascular Diseases (2)  ·  Diabetes Complications (2)  ·  Diabetes Mellitus (2)  ·  Diabetic Angiopathies (2)  ·  Retinal Diseases (2)  ·  Vascular Diseases (2)  ·  Glucose Metabolism Disorders (1)  ·  Lens Diseases (1)  ·  Metabolic Diseases (1)  ·  Nutritional and Metabolic Diseases (1)

Interventions

Phacoemulsification (2)  ·  Calcium Dobesilate (1)  ·  KH902 fusion protein (1)  ·  Ranibizumab (1)  ·  Staining and Labeling (1)  ·  Trypan Blue (1)  ·  prednisolone acetate (1)

Sponsors

Assiut University (1)  ·  Baylor Research Institute (1)  ·  Eye & ENT Hospital of Fudan University (1)  ·  Ruijin Hospital (1)  ·  University Hospital, Strasbourg, France (1)

Countries

China (1)  ·  Egypt (1)  ·  France (1)

Top investigators

Jin Yang, MD, ph.D. (1)  ·  Zijian Yang, Dr (1)

Results publications

PMID 31032113, PMID 40597813